Frequency of Antibiotic Resistance and Virulence Factors in Streptococcus agalactiae Isolated from Vaginal and Urine Samples of Pregnant Women in Yazd, Iran: A Cross-sectional Study
Abstract
Background: Streptococcus agalactiae, or group B Streptococcus (GBS), is part of the normal flora of the female vagina and gastrointestinal tract. The capsular serotype, virulence factors, and antibiotic resistance determine the pathogenic properties of this bacterium. Objectives: This cross-sectional study aims to determine the frequency of antibiotic resistance and virulence factor genes in GBS isolated from vaginal and urine samples of pregnant women in Yazd, Iran. Methods: A cross-sectional study was conducted from January 2021 to May 2022 in Yazd, Iran. Ninety GBS isolates from pregnant women were subjected to analysis. The Kirby-Bauer method was performed to assess antibiotic resistance of GBS to penicillin, clindamycin, erythromycin, tetracycline, and levofloxacin. Genotypic investigation of resistance to erythromycin, tetracycline, and clindamycin genes, as well as adhesion and invasion protein genes, was also evaluated by molecular methods. Results: The highest resistance was related to tetracycline (93.3%), and the resistance rates to clindamycin and erythromycin were 13.3% and 12.2%, respectively. The frequencies of scpB, laminin-binding protein (lmb), fbsA, and fbsB genes in vaginal samples were 97.8%, 93.3%, 96.7%, and 83.3%, respectively, and in urine samples were 100% for all genes; however, the hvgA gene was not found in any vaginal or urine isolates. The distribution of antibiotic resistance genes was tetM (87%), int-Tn (72.2%), ermA (42.2%), ermB (12.2%),…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.